as embodied and broadly described herein , the disclosures herein provide detailed embodiments of the invention . however , the disclosed embodiments are merely exemplary of the invention that may be embodied in various and alternative forms . therefore , there is no intent that specific structural and functional details should be limiting , but rather the intention is that they provide a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention . fig2 depicts an embodiment of the medication delivery device 200 . this device provides a treatment for otoacoustic emissions resulting from damage to inner ear audio receptor cells ( inner hair cells with stereocilia ) that vibrate and outer hair cells that convert the signals into tension on a vibrating membrane . the resulting sounds are one of a number of possible causes of tinnitus . the etiology of tinnitus is unknown but may be a result of damage to the receptor cells and may be accompanied by hearing loss . the device may also be used to treat other conditions in the inner ear , such as non - auditory diseases , particularly inner ear infections and meniere &# 39 ; s disease . preferably , device 200 is sized and shaped to fit within the ear canal of a human ( although the device may be used on other animals ). device 200 is a non - invasive device . preferably device 200 is insertable and removable from the ear canal without penetrating or piercing the body of the patient . preferably , device 200 is not implanted . preferably , device 200 can be inserted into either ear and two devices can be inserted into both ears simultaneously . device 200 can be held within the ear canal by friction , adhesive , or another non - invasive method . preferably , device 200 is has a universal size and shape to fit into the majority of ears . however , device 200 can come in various sizes and / or shapes , for example to fit within various sized ear canals or for children and adults . furthermore , device 200 can be custom molded for each patient . preferably , the entirety of device 200 is capable of fitting within the ear canal . in other embodiments , device 200 may protrude from the ear canal or only a portion of device 200 may be inserted into the ear canal . preferably device 200 is molded to fit within the ear canal . however , device 200 can be cylindrical or have another shape . for example , the majority of the components of device 200 may be contained in a housing positioned behind the patient &# 39 ; s ear and the delivery nozzle may be inserted into the ear to avoid blocking sound from entering the ear canal and disrupting hearing . preferably , device 200 is waterproof or water resistant . in the preferred embodiment , device 200 is a self - contained device . the device preferably includes a pressurized container ( or vessel ) 205 , a fill / delivery nozzle 210 , a control mechanism 215 , a microprocessor 225 , a power source 230 , and a controller . the device may further include flexible seals 230 and 235 to prevent blowback , mitigate any leakage , and protect the components from external elements . in certain embodiments , device 200 may be coupled to a hearing aid and be capable of using the hearing aid &# 39 ; s power source and / or microprocessor . device 200 in combination with a hearing aid may mitigate hearing loss due to the device being placed within the ear canal . pressurized container 205 is preferably positioned so that when device 200 is inserted into the ear , pressurized container is adjacent to the ear drum . however , in other embodiments , pressurized container 205 can have other positions . pressurized container 205 is preferably adapted to hold liquid or gas under pressure . for example pressurized container 205 may be capable of withstanding between 10 and 1000 psi of pressure , preferably between 20 and 500 psi , and more preferably between 30 and 100 psi . preferably , pressurized container has a capacity of less than one milliliter , preferably between 1 and 500 microliters , and more preferably between 50 and 100 microliters of contents . preferably , pressurized container 205 is made of plastic , however , pressurized container 205 can be made of glass , metal , fabric , or another manmade or naturally occurring material , or a combination thereof . preferably , pressurized container 205 is hypoallergenic and does not react with its contents . the inner or outer surface of pressurized container 205 may be coated to prevent reactions . pressurized container 205 is preferably refillable or rechargeable , however pressurized container 205 may be prefilled and replaceable . preferably , pressurized container 205 is filled with a medication capable of diffusing through the ear drum into the inner ear . as the ear drum is a membrane , many fluids and gasses are capable of diffusing through the membrane . preferably , the contents are in gaseous or vapor form . for example , pressurized container 205 may be filled with one or more of o 2 , n 2 , co 2 , no 3 , h e , a r , antibiotics , and medical gasses . preferably , the contents are administered in one or more therapeutically effective doses . the therapeutically effective does and concentration of the contents preferably can be determined by one of skill in the art through empirical testing . pressurized container 205 preferably contains a control mechanism 215 . for example , control mechanism 215 may be a control valve . control mechanism 215 is preferably adapted to release a specified amount of the contents of pressurized container 205 . control mechanism 215 preferably releases the contents through nozzle 210 . nozzle 210 is preferably positioned at an end of pressurized container 205 such that nozzle 210 touches , is adjacent to , or is in near proximity to the ear drum . in the preferred embodiment , control mechanism 215 and nozzle 210 are capable of being used to fill pressurized container 205 and delivering doses ( or amounts ) of the contents of pressurized container 205 . in other embodiments , pressurized container 205 may have a separate fill valve and control mechanism 215 and / or nozzle 210 are one way devices . nozzle 210 may be capable of atomizing the contents of pressurized container 205 , for example if the contents are a liquid . in the preferred embodiment , control mechanism 215 is controlled by microprocessor 225 . preferably , microprocessor 225 is positioned outside pressurized container 205 and in communication with control mechanism 215 . for clarity of explanation , the illustrative system embodiment is presented as comprising individual functional blocks ( including functional blocks labeled as a “ microprocessor ”). the functions these blocks represent may be provided through the use of either shared or dedicated hardware , including , but not limited to hardware capable of executing software . for example the functions of one or more microprocessors presented in fig2 may be provided by a single shared microprocessor or multiple microprocessors . ( use of the term “ microprocessor ” should not be construed to refer exclusively to hardware capable of executing software .) illustrative embodiments comprise microprocessor and / or digital signal processor ( dsp ) hardware , read - only memory ( rom ) for storing software performing the operations discussed below , and random access memory ( ram ) for storing results . very large scale integration ( vlsi ) hardware embodiments , as well as custom vlsi circuitry in combination with a general purpose dsp circuit , may also be provided . preferably , microprocessor 225 opens and closes control mechanism 215 to emit a micro dose of the stored medication . for example , microprocessor 225 may instruct control mechanism 215 to emit between 1 and 500 microliters , preferably between 1 and 100 microliters , and more preferably between 1 and 20 microliters of the stored substance . preferably , microprocessor 225 is programmable to vary the amount of the micro dosage and the number of doses that can be release in a period of time ( e . g . per hour , 24 hours , or number of days ). preferably , microprocessor 225 and device 200 are powered by power source 230 . power source 230 can be a rechargeable battery , a replaceable battery , mechanically powered , solar powered , electrochemically powered , bio - electrically powered , powered by the patient &# 39 ; s body ( e . g . movement or heat ), or another power source . in certain embodiments , the whole device 200 may be disposable once the power source is no longer capable of supplying power or once the pressurized container 205 is empty . preferably , microprocessor 225 receives instructions from an external controller . preferably , the external controller is a wireless device . for example the external controller can be a tablet devices , wireless web - enabled or “ smart ” phone ( e . g ., research in motion &# 39 ; s blackberry ™, an android ™ device , apple &# 39 ; s iphone ™) application , other wireless phones , a wearable internet connected device , or a dedicated hand held controller . preferably , the system is technology agnostic . communication can occur over any communications network known in the art , including but not limited to wired networks , wireless networks , zigbee networks , bluetooth networks , z - wave networks , wifi networks , wimax networks , rf networks , local area networks ( lan ), internet networks , wide area networks ( wan ), cellular telephone network , 900 mhz wireless networks , and satellite networks . in other embodiments the controller may be directly wired or otherwise coupled to device 200 . preferably , the external controller is programmed for how to administer the medication ( e . g . how often , in what doses , and for how long ) and sends signals to the microprocessor as necessary . additionally , a patient may be able to request a dose on demand . for example , if the patient is experiencing pain or discomfort , the patient may be able to manually activate , push a button , or otherwise indicate to the controller to emit a dose of the medication . in other embodiments , the patient may be able to push a button on device 200 or otherwise directly interact with device 200 to request a dose . other embodiments and uses of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein . all references cited herein , including all publications , u . s . and foreign patients and patient applications , are specifically and entirely incorporated by reference . it is intended that the specification and examples be considered exemplary only with the true scope and spirit of the invention indicated by the following claims . furthermore , the term “ comprising of ” includes the terms “ consisting of ” and “ consisting essentially of .” all examples illustrate embodiments of the invention , but should not be viewed as limiting the scope of the invention .
inner ear treatment delivery devices and methods are disclosed . the device includes a pressurized container filled with a content , a control mechanism within the pressurized container , a nozzle coupled to the control valve , a microprocessor adapted to operate the control valve , and a power source providing energy to the device . the device administers at least one dose of the content to a patient &# 39 ; s inner ear .